Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hangzhou Tongjian Technology is a private Chinese healthcare-related company focused on inspection and testing services and the sale of medical devices rather than drug R&D. Public Chinese business-registry sources describe the company as active, founded in 2018 in Hangzhou, and operating in biotechnology promotion/services, inspection and testing, and Class I-III medical device distribution. Recent procurement records and business-scope disclosures indicate activity in hair-based drug testing and related healthcare or public-health procurement projects. The company appears to function more as a healthcare service, diagnostics-support, and medical-device commercialization business than as a therapeutics developer. No credible evidence was found of a proprietary clinical-stage drug pipeline, named therapeutic programs, or pharma partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hangzhou Tongjian Technology.